29 June 2026
Velindre University NHS Trust is delighted to announce that Carl James has been appointed its new substantive Chief Executive Officer (CEO).
Carl is the Interim Chief Executive and has worked for the Trust since 2013.
He has a strong record of working in in the public sector in local authorities, emergency services and the Welsh Government leading change to deliver better services. During his time at Velindre, Carl has been responsible for strategic planning, service transformation, estates and major capital projects, performance management and sustainability. He is also the Programme Director for the new Velindre Cancer Centre project.
Carl has degrees in political geography and a Masters in Environmental Policy and Law, Strategic Human Resource management and an MBA in Business Management. He lives in Bridgend with his wife and family and has a passion for sport enjoying rugby, cricket, football, cycling and squash and supporting charitable causes. He has raised £25,000 for the Velindre Cancer Charity so far.
Trust Chair, Sara Moseley, said “We are delighted that Carl has been appointed to the CEO post. This is an organisation with a strong sense of purpose and a clear ambition for the future, and we are confident he will deliver his work in line with our organisational values and culture. Carl's leadership will be key as we continue to build on our strengths, innovate and deliver the very best for the people and communities we serve.”
The appointment follows a rigorous and highly competitive recruitment process, supported by a specialist executive search consultancy. The process attracted a strong field of candidates from across the UK and beyond and included a comprehensive assessment and interview programme involving key stakeholders. This approach has ensured the appointment of a high‑calibre leader with the skills, experience and values to lead Velindre into its next phase.
Carl said: “I am honoured to be leading the Trust at such an important time for the organisation which is widely recognised for the quality of specialist services it delivers, its strong sense of purpose and the difference it makes to people across Wales. Looking ahead, the opportunity is significant. We are well placed to extend our impact and play an even greater role in delivering high quality care and the best possible patient outcomes across Wales. I am proud to continue working alongside our outstanding staff, Local Health Boards and stakeholders as we shape the next phase of the Trust’s development and contribute to the future of direction of NHS Wales.”